ATE266660T1 - Piperidin-derivate und ihre verwendung als serotonin rezeptor antagonisten - Google Patents

Piperidin-derivate und ihre verwendung als serotonin rezeptor antagonisten

Info

Publication number
ATE266660T1
ATE266660T1 AT00986241T AT00986241T ATE266660T1 AT E266660 T1 ATE266660 T1 AT E266660T1 AT 00986241 T AT00986241 T AT 00986241T AT 00986241 T AT00986241 T AT 00986241T AT E266660 T1 ATE266660 T1 AT E266660T1
Authority
AT
Austria
Prior art keywords
receptor antagonists
serotonin receptor
piperidine derivatives
withdrawal
nicotine
Prior art date
Application number
AT00986241T
Other languages
English (en)
Inventor
John Xiaoqiang He
Nicholas Allan Honigschmidt
Todd Jonathan Kohn
Vincent Patrick Rocco
Patrick Gianpietro Spinazze
Kumiko Takeuchi
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE266660T1 publication Critical patent/ATE266660T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT00986241T 1999-12-20 2000-12-06 Piperidin-derivate und ihre verwendung als serotonin rezeptor antagonisten ATE266660T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17272399P 1999-12-20 1999-12-20
PCT/US2000/032426 WO2001046179A1 (en) 1999-12-20 2000-12-06 Piperidine derivatives and their use as serotonin receptor antagonists

Publications (1)

Publication Number Publication Date
ATE266660T1 true ATE266660T1 (de) 2004-05-15

Family

ID=22628938

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00986241T ATE266660T1 (de) 1999-12-20 2000-12-06 Piperidin-derivate und ihre verwendung als serotonin rezeptor antagonisten

Country Status (7)

Country Link
US (1) US6784180B2 (de)
EP (1) EP1250336B1 (de)
AT (1) ATE266660T1 (de)
AU (1) AU2251801A (de)
DE (1) DE60010758T2 (de)
ES (1) ES2220582T3 (de)
WO (1) WO2001046179A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040110691A1 (en) * 2001-11-13 2004-06-10 Stamler Jonathan S. Thiol reactive agents as a therapeutic modality
WO2004082686A2 (en) * 2003-03-13 2004-09-30 Dynogen Pharmaceuticals, Inc. Use of compounds with combined 5-ht1a and ssri activities to treat sexual dysfunction
US20040223912A1 (en) * 2003-05-07 2004-11-11 Montalto Michael Christopher Compositions and methods for non-invasive imaging of soluble beta-amyloid
WO2004100998A2 (en) * 2003-05-07 2004-11-25 General Electric Company Compositions and methods for non-invasive imaging of soluble beta-amyloid
JP5070042B2 (ja) * 2004-05-03 2012-11-07 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 選択的アンドローゲン受容体モジュレーター(sarms)としての新規インドール化合物
TWI320783B (en) 2005-04-14 2010-02-21 Otsuka Pharma Co Ltd Heterocyclic compound
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
DK2948143T3 (da) * 2013-01-24 2021-07-26 Minerva Neurosciences Inc Anvendelse af phenoxypropylaminforbindelser til behandling af depression
CN112955145A (zh) 2018-09-04 2021-06-11 密涅瓦神经科学有限公司 使用苯氧丙胺化合物治疗疼痛的方法
CN119059962A (zh) * 2024-09-09 2024-12-03 郑州药领医药科技有限公司 一种n保护的2,2-二甲基哌啶-4-酮的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA954689B (en) * 1994-06-08 1996-01-29 Lundbeck & Co As H 4-Aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl) piperidines tetrahydropyridines or piperazines
US5741789A (en) * 1995-01-17 1998-04-21 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5846982A (en) * 1996-06-14 1998-12-08 Eli Lilly And Company Inhibition of serotonin reuptake
US5912256A (en) 1996-06-20 1999-06-15 Eli Lilly And Company Compounds having effects on serotonin-related systems
AU4977899A (en) * 1998-07-27 2000-02-21 Eli Lilly And Company Treatment of anxiety disorders

Also Published As

Publication number Publication date
DE60010758D1 (de) 2004-06-17
US6784180B2 (en) 2004-08-31
EP1250336A1 (de) 2002-10-23
WO2001046179A1 (en) 2001-06-28
DE60010758T2 (de) 2005-05-12
AU2251801A (en) 2001-07-03
EP1250336B1 (de) 2004-05-12
US20030225281A1 (en) 2003-12-04
ES2220582T3 (es) 2004-12-16

Similar Documents

Publication Publication Date Title
ATE203990T1 (de) Indolderivat als 5-ht1a antagonist und als inhibitor der serotonin-wiederaufnahme
NO20063599L (no) Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister
SE0303180D0 (sv) Novel compounds
SE0302232D0 (sv) Novel Compounds
DE60110749D1 (de) Pyridinderivative als angiogenese- und/oder vegf-rezeptor-tyrosinkinase-inhibitoren
NO20070336L (no) Indolderivater som histamin-reseptorantagonister
NO20032861L (no) Heteroarylurea nevropeptid Y Y5-reseptorantagonister
ATE384050T1 (de) Benzazepinderivate als histamin-h3-antagonisten
BRPI0507180A (pt) derivados de 1-isopropil-2-oxo-1,2-diidropiridina-3-carboxamida tendo atividade agonìstica de receptor 5-ht4
TR200101155T2 (tr) 4-Aroil Piperidin CCR-3 Reseptör Antagonistleri III
DE60038686D1 (de) Oheptan-derivate und ihre verwendung als integrin-rezeptor-antagonisten
DE60230683D1 (de) 3,6-disubstituierte azabicyclo-3.1.0 hexan-derivat
BR0009278A (pt) 1-arenossulfonil-2-aril-pirrolidina e derivados depiperidina
MXPA05011018A (es) Compuestos de 4-fenil piperidna y sus usos como moduladores de receptores opioides.
ATE355265T1 (de) Biphenylcarboxamidderivate und ihre verwendung als p38 kinase inhibitoren
ATE266660T1 (de) Piperidin-derivate und ihre verwendung als serotonin rezeptor antagonisten
MY153719A (en) Prokineticin 1 receptor antagonists
TW200716566A (en) Prokineticin 2 receptor antagonists
DE60327375D1 (de) Arylindenopyridin- und arylindenopyrimidinverbindungen und ihre verwendung als adenosin-a2a-rezeptor antagonisten
ATE251614T1 (de) Piperazinderivate als neurokinin-antagonisten
DE602005009512D1 (de) 3-((hetero)arylsulfonyl)-8-ä(aminoalkyl)oxyüchinoline als antagonisten des 5-ht6-rezeptors zur behandlung von erkrankungen des zns
DE602005018381D1 (de) 1-(hetero)aryl-3-aminopyrrolidinderivate zur verwendung als antagonisten des mglur3-rezeptors
ATE319709T1 (de) Indolderivate zur behandlung von depression und angstzuständen
ATE383343T1 (de) Imidazolderivate verwendbar als histamin h3 rezeptorliganden
EA200602081A1 (ru) Пиридиновые производные алкилоксиндолов в качестве агентов, активных в отношении рецептора 5-нт7

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties